科研动态

论文

当前位置: 首页 >> 科研成果 >> 论文 >> 正文

2024年发表SCI论文

发布日期:2026-07-17    作者:     来源:     点击:

[1] Li W, Liu L, Li X, et al. A Ni(II)MOF-based hypersensitive dual-function luminescent sensor towards the 3-nitrotyrosine biomarker and 6-propyl-2-thiouracil antithyroid drug in urine[J]. Journal of materials chemistry. B, 2024,12(45):11800-11809.

[2] Hui X, Farooq M A, Chen Y, et al. A novel strategy of co-expressing CXCR5 and IL-7 enhances CAR-T cell effectiveness in osteosarcoma[J]. Frontiers in immunology, 2024,15:1462076.

[3] Jin K, Huang P, Li B, et al. A Single-Copy Sensitive and Field-Deployable One-Pot RT-RPA CRISPR/Cas12a Assay for the Specific Visual Detection of the Nipah Virus[J]. Transboundary and emerging diseases, 2024,2024:4118007.

[4] Huang S, Lu H, Chen J, et al. Advances in drug delivery-based therapeutic strategies for renal fibrosis treatment[J]. Journal of materials chemistry. B, 2024,12(27):6532-6549.

[5] Mo H, Zhang X, Ren L. Analysis of neuroglia and immune cells in the tumor microenvironment of breast cancer brain metastasis[J]. Cancer biology & therapy, 2024,25(1):2398285.

[6] Yang M, Wu S, Dai Q, et al. Andrographolide prevents renal fibrosis via decelerating lipotoxicity-mediated premature senescence of tubular epithelial cells[J]. Biochemical pharmacology, 2024,230(Pt 3):116615.

[7] Zheng J, Yang B, Liu S, et al. Applications of Exosomal miRNAs from Mesenchymal Stem Cells as Skin Boosters[J]. Biomolecules, 2024,14(4):459.

[8] Lei X, Xiao R, Chen Z, et al. Augmenting antitumor efficacy of Th17-derived Th1 cells through IFN-γ-induced type I interferon response network via IRF7[J]. Proceedings of the National Academy of Sciences of the United States of America, 2024,121(47):e1882847175.

[9] Liu S, Zhang W, Tian S, et al. B cell-intrinsic IFN-γ promotes excessive CD11c(+) age-associated B cell differentiation and compromised germinal center selection in lupus mice[J]. Cellular immunology, 2024,405-406:104883.

[10] Yang Z, Zhang Z, Li L, et al. Bioengineered Artificial Extracellular Vesicles Presenting PD-L1 and Gal-9 Ameliorate New-Onset Type 1 Diabetes[J]. Diabetes, 2024,73(8):1325-1335.

[11] Lin X, Yao Y, Wen Q, et al. Calceolarioside B inhibits SARS-CoV-2 Omicron BA.2 variant cell entry and modulates immune response[J]. Virology journal, 2024,21(1):329.

[12] Lan H, Shu W, Jiang D, et al. Cas-based bacterial detection: recent advances and perspectives[J]. The Analyst, 2024,149(5):1398-1415.

[13] Zhang P, Liu B, Zhang S, et al. Clinical application of targeted next-generation sequencing in severe pneumonia: a retrospective review[J]. Critical care (London, England), 2024,28(1):225.

[14] Zhu X, Guo C, Xu S, et al. Clinical distribution of carbapenem genotypes and resistance to ceftazidime-avibactam in Enterobacteriaceae bacteria[J]. Frontiers in cellular and infection microbiology, 2024,14:1345935.

[15] Liu Y, Chen P, Zhou T, et al. Co-culture of STRO1 + human gingival mesenchymal stem cells and human umbilical vein endothelial cells in 3D spheroids: enhanced in vitro osteogenic and angiogenic capacities[J]. Frontiers in cell and developmental biology, 2024,12:1378035.

[16] Shu W, Huang Q, Chen R, et al. Complicated role of ALKBH5 in gastrointestinal cancer: an updated review[J]. Cancer cell international, 2024,24(1):298.

[17] Hu D, Yang Z, Zhang J, et al. Copper homeostasis; A rapier between mycobacteria and macrophages[J]. FASEB bioAdvances, 2024,7(1):e1484.

[18] Liao J, Chen R, Lin B, et al. Cross-Talk between the TGF-β and Cell Adhesion Signaling Pathways in Cancer[J]. International journal of medical sciences, 2024,21(7):1307-1320.

[19] Deng L, Qiu Y, Zeng Y, et al. Current and promising applications of MOF composites in the healing of diabetes wounds[J]. RSC medicinal chemistry, 2024,15(8):2601-2621.

[20] Zhang G, Liu J, Li S, et al. Cytochalasin H enhances sensitivity to gefitinib in non-small-cell lung cancer cells through inhibiting EGFR activation and PD-L1 expression[J]. Scientific reports, 2024,14(1):25276.

[21] Wen S, Zheng X, Yin W, et al. Dental stem cell dynamics in periodontal ligament regeneration: from mechanism to application[J]. Stem cell research & therapy, 2024,15(1):389.

[22] Jin W, Jiang S, Liu X, et al. Disorganized chromatin hierarchy and stem cell aging in a male patient of atypical laminopathy-based progeria mandibuloacral dysplasia type A[J]. Nature communications, 2024,15(1):10046.

[23] Zhang W, Zeng S, Huang J, et al. Down-regulation of O-GlcNAcylation alleviates insulin signaling pathway impairment following arsenic exposure via suppressing the AMPK/mTOR-autophagy pathway[J]. Toxicology letters, 2024,397:67-78.

[24] Chen S, Huang L, Liu B, et al. Dynamic changes in butyrate levels regulate satellite cell homeostasis by preventing spontaneous activation during aging[J]. Science China. Life sciences, 2024,67(4):745-764.

[25] Cui H, Cui X, Yang X, et al. Effect of ATG8 or SAC1 deficiency on the cell proliferation and lifespan of the long-lived PMT1 deficiency yeast cells[J]. FEMS microbiology letters, 2024,371:d121.

[26] Zeng J, Chen S, Li C, et al. Erratum: Mesenchymal stem/stromal cells-derived IL-6 promotes nasopharyngeal carcinoma growth and resistance to cisplatin via upregulating CD73 expression: Erratum[J]. Journal of Cancer, 2024,15(19):6418-6419.

[27] Li W, Zhuang Y, Shao S, et al. Essential contribution of the JAK/STAT pathway to carcinogenesis, lytic infection of herpesviruses and pathogenesis of COVID?19 (Review)[J]. Molecular medicine reports, 2024,29(3):39.

[28] Zhan R, Yu H, Zhang G, et al. Exosomal EGFR and miR-381-3P Mediate HPV-16 E7 Oncoprotein-Induced Angiogenesis of Non-Small Cell Lung Cancer[J]. Frontiers in bioscience (Landmark edition), 2024,29(5):189.

[29] Yao H, Wang X, Chi J, et al. Exploring Novel Antidepressants Targeting G Protein-Coupled Receptors and Key Membrane Receptors Based on Molecular Structures[J]. Molecules (Basel, Switzerland), 2024,29(5):964.

[30] Ling X, Jiao Q, Lin D, et al. Extrachromosomal circular DNA containing DTX1 promotes cell growth in hydroquinone-induced malignantly transformed cells by regulating the transcription of DTX1[J]. BMC cancer, 2024,24(1):1448.

[31] Liu X, Zhang W, Han Y, et al. FOXP3(+) regulatory T cell perturbation mediated by the IFNγ-STAT1-IFITM3 feedback loop is essential for anti-tumor immunity[J]. Nature communications, 2024,15(1):122.

[32] Ding J, Liu Y, Liu Z, et al. Glutathione-Responsive Organosilica Hybrid Nanosystems for Targeted Dual-Starvation Therapy in Luminal Breast Cancer[J]. Molecular pharmaceutics, 2024,21(2):745-759.

[33] Lin J, Chen D, Yan Y, et al. Gut microbiota: a crucial player in the combat against tuberculosis[J]. Frontiers in immunology, 2024,15:1442095.

[34] Li H, Huang H, Huang W, et al. Hepatitis C virus subtype diversity and transmission clusters characteristics among drug users in Zhuhai, South China[J]. BMC infectious diseases, 2024,24(1):451.

[35] Yang Z, Wang J, Pi J, et al. Identification and Validation of Genes Related to Macrophage Polarization and Cell Death Modes Under Mycobacterium tuberculosis Infection[J]. Journal of inflammation research, 2024,17:1397-1411.

[36] Wei Y, Zhang Z, Xue T, et al. In Situ Synthesis of an Immune-Checkpoint Blocker from Engineered Bacteria Elicits a Potent Antitumor Response[J]. ACS synthetic biology, 2024,13(6):1679-1693.

[37] Ouyang S, Lu P, Li J, et al. Inhaled tea polyphenol-loaded nanoparticles coated with platelet membranes largely attenuate asthmatic inflammation[J]. Respiratory research, 2024,25(1):311.

[38] Chang X, Zhang S, Li C, et al. Inhibitory Effect of Lactobacillus Paracasei CMU-Pb-L5 In a Subcutaneous Transplanted Tumor Model of Colorectal Cancer[J]. International journal of medical sciences, 2024,21(13):2525-2536.

[39] Shahzad A, Teng Z, Yameen M, et al. Innovative lipid nanoparticles: A cutting-edge approach for potential renal cell carcinoma therapeutics[J]. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2024,180:117465.

[40] Wu Y, Chen J, Zhu R, et al. Integrating TCGA and Single-Cell Sequencing Data for Hepatocellular Carcinoma: A Novel Glycosylation (GLY)/Tumor Microenvironment (TME) Classifier to Predict Prognosis and Immunotherapy Response[J]. Metabolites, 2024,14(1):51.

[41] Huang K, Zhou H, Chen M, et al. Interleukin-26 expression in tuberculosis disease and its regulatory effect in macrophage polarization and intracellular elimination of Mycobacterium tuberculosis[J]. Frontiers in cellular and infection microbiology, 2024,14:1455819.

[42] Jin H, Zhao Y, Yao Y, et al. Intratracheal Administration of Stem Cell Membrane-Cloaked Naringin-Loaded Biomimetic Nanoparticles Promotes Resolution of Acute Lung Injury[J]. Antioxidants (Basel, Switzerland), 2024,13(3):282.

[43] Wu Y, Li Y, Liu G, et al. LC-MS-based quantitation of proteomic changes induced by Norcantharidin in MTB-Treated macrophages[J]. Proteome science, 2024,22(1):13.

[44] Pi J, Chen D, Wang J, et al. Macrophage targeted graphene oxide nanosystem synergize antibiotic killing and host immune defense for Tuberculosis Therapy[J]. Pharmacological research, 2024,208:107379.

[45] Wang Y, Zhou L, Pan X, et al. Metabolic Blockade-Based Genome Mining of Sea Anemone-Associated Streptomyces sp. S1502 Identifies Atypical Angucyclines WS-5995 A-E: Isolation, Identification, Biosynthetic Investigation, and Bioactivities[J]. Marine drugs, 2024,22(5):195.

[46] Zhan X, Yuan W, Ma R, et al. Mmu-let-7a-5p inhibits macrophage apoptosis by targeting CASP3 to increase bacterial load and facilities mycobacterium survival[J]. PloS one, 2024,19(9):e308095.

[47] Deng L, Guo M, Deng Y, et al. MOF-Based Platform for Kidney Diseases: Advances, Challenges, and Prospects[J]. Pharmaceutics, 2024,16(6):793.

[48] Zhang X, Ding G, Yang X, et al. Myriocin enhances the clearance of M. tuberculosis by macrophages through the activation of PLIN2[J]. mSphere, 2024,9(7):e25724.

[49] Liu Y, Wang J, Yang J, et al. Nanomaterial-mediated host directed therapy of tuberculosis by manipulating macrophage autophagy[J]. Journal of nanobiotechnology, 2024,22(1):608.

[50] Zeng J, Zhang Y, Fang Y, et al. Natural Product Quercetin-3-methyl ether Promotes Colorectal Cancer Cell Apoptosis by Downregulating Intracellular Polyamine Signaling[J]. International journal of medical sciences, 2024,21(5):904-913.

[51] Chen R, Lo H H, Yang C, et al. Natural small-molecules reverse Xeroderma Pigmentosum Complementation Group C (XPC) deficient-mediated drug-resistance in renal cell carcinoma[J]. Phytomedicine : international journal of phytotherapy and phytopharmacology, 2024,124:155310.

[52] Zhang J, Cao J, Wang L, et al. Neoantigen sequestrated autophagosomes as therapeutic cancer vaccines[J]. Journal of controlled release : official journal of the Controlled Release Society, 2024,376:369-381.

[53] Chen X, Xuan C, Lin J, et al. One-tube B7-H3 detection based on isothermal exponential amplification and dendritic hybridization chain reaction[J]. Nanoscale advances, 2024,6(8):2129-2135.

[54] Zhao Y, Yao Y, Fan S, et al. Oral delivery of pH-sensitive nanoparticles loaded Celastrol targeting the inflammatory colons to treat ulcerative colitis[J]. Journal of tissue engineering, 2024,15:1788756196.

[55] Zheng T, Deng J, Wen J, et al. p38α deficiency ameliorates psoriasis development by downregulating STAT3-mediated keratinocyte proliferation and cytokine production[J]. Communications biology, 2024,7(1):999.

[56] Chen L, Liu S, Zhang Y, et al. Palmitic acid-capped MIL-101-Al as a nano-adjuvant to amplify immune responses against Pseudomonas aeruginosa[J]. Nanoscale, 2024,16(21):10306-10317.

[57] Wang Z, Su Y, Zhao L, et al. Pan-Cancer Single-Cell Transcriptomic Analysis Reveals Divergent Expression of Embryonic Proangiogenesis Gene Modules in Tumorigenesis[J]. Cancer medicine, 2024,13(21):e70373.

[58] Zhou J, Zhang X, Mao W, et al. Pathological features of gastric?type endocervical adenocarcinoma: A report of two cases[J]. Oncology letters, 2024,27(4):149.

[59] Fan S, Zhao D, Wang J, et al. Photothermal and host immune activated therapy of cutaneous tuberculosis using macrophage targeted mesoporous polydopamine nanoparticles[J]. Materials today. Bio, 2024,28:101232.

[60] Liu W, Huang X, Luo W, et al. Progerin Inhibits the Proliferation and Migration of Melanoma Cells by Regulating the Expression of Paxillin[J]. OncoTargets and therapy, 2024,17:227-242.

[61] Deng Y, Guo M, Zhou L, et al. Prospects, advances and biological applications of MOF-based platform for the treatment of lung cancer[J]. Biomaterials science, 2024,12(15):3725-3744.

[62] Li W, Deng X, Zhang Z, et al. Renal-Clearable Organic Probes From D-A-D Type Aza-BODIPY Fluorophores for Multiphoton Deep-Brain Imaging[J]. Small (Weinheim an der Bergstrasse, Germany), 2024,20(50):e2403994.

[63] Li C, Wang J, Xu J, et al. Roles of HIF-1α signaling in Mycobacterium tuberculosis infection: New targets for anti-TB therapeutics?[J]. Biochemical and biophysical research communications, 2024,711:149920.

[64] Lei Y, Xu N, Niu C, et al. Specific immunological characteristics and risk factor of XBB variants re-infection in nasopharyngeal carcinoma patients after BA.5 infection[J]. Virology, 2024,597:110142.

[65] Cao K, Wang R, Li L, et al. Targeting DDX11 promotes PARP inhibitor sensitivity in hepatocellular carcinoma by attenuating BRCA2-RAD51 mediated homologous recombination[J]. Oncogene, 2024,43(1):35-46.

[66] Wu W, Li J, Chen S, et al. The airway neuro-immune axis as a therapeutic target in allergic airway diseases[J]. Respiratory research, 2024,25(1):83.

[67] Lian R, Zhang X, Liu Z, et al. The Association of ACA on Embryonic Development and Pregnancy Outcomes in Patients Undergoing IVF/ICSI Treatment[J]. American journal of reproductive immunology (New York, N.Y. : 1989), 2024,92(6):e70025.

[68] Su Q, Zheng Z, Xie Y, et al. The diagnostic value of serum Ephrin-A1 in patients with colorectal cancer[J]. Scientific reports, 2024,14(1):31194.

[69] Zeng Z, Zeng X, Li X, et al. The Efficacy and Safety of Polyethylene Glycol Cholesterol- and Tocopherol Polyethylene Glycol 1000 Succinate-Modified Transforming Growth Factor β1 Small Interfering RNA Lipid Nanoparticles in the Treatment of Paclitaxel-Resistant Non-Small-Cell Lung Cancer[J]. Pharmaceutics, 2024,16(1):75.

[70] Liang Z, Ning R, Wang Z, et al. The emerging roles of UFMylation in the modulation of immune responses[J]. Clinical and translational medicine, 2024,14(9):e70019.

[71] Yousuf S, Luo H, Zeng M, et al. Unveiling microbial communities with EasyAmplicon: A user-centric guide to perform amplicon sequencing data analysis[J]. iMetaOmics, 2024,1(2):e42.

[72] Huang Y, Chan S, Chen S, et al. Wnt/β-catenin signalling activates IMPDH2-mediated purine metabolism to facilitate oxaliplatin resistance by inhibiting caspase-dependent apoptosis in?colorectal cancer[J]. Journal of translational medicine, 2024,22(1):133.